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Purpose: To report the clinical and genetic study of patients with autosomal dominant aniridia.
Methods: We studied ten patients with aniridia from three families of Egyptian origin. All patients underwent full
ophthalmologic, general and neurological examination, and blood drawing. Cerebral magnetic resonance imaging was
performed in the index case of each family. Genomic DNA was prepared from venous leukocytes, and direct sequencing
of all the exons and intron–exon junctions of the Paired Box gene 6 (PAX6) was performed after PCR amplification.
Phenotype description, including ophthalmic and cerebral anomalies, mutation detection in PAX6 and phenotype-genotype
correlation was acquired.
Results: Common features observed in the three families included absence of iris tissue, corneal pannus with different
degrees of severity, and foveal hypoplasia with severely reduced visual acuity. In Families 2 and 3, additional findings,
such as lens dislocation, lens opacities or polar cataract, and glaucoma, were observed. We identified two novel (c.
170-174delTGGGC [p.L57fs17] and c.475delC [p.R159fs47]) and one known (c.718C>T [p.R240X]) PAX6 mutations
in the affected members of the three families. Systemic and neurological examination was normal in all ten affected
patients. Cerebral magnetic resonance imaging showed absence of the pineal gland in all three index patients. Severe
hypoplasia of the brain anterior commissure was associated with the p.L57fs17 mutation, absence of the posterior
commissure with p.R159fs47, and optic chiasma atrophy and almost complete agenesis of the corpus callosum with
p.R240X.
Conclusions: We identified two novel PAX6 mutations in families with severe aniridia. In addition to common phenotype
of aniridia and despite normal neurological examination, absence of the pineal gland and interhemispheric brain anomalies
were observed in all three index patients. The heterogeneity of PAX6 mutations and brain anomalies are highlighted. This
report emphasizes the association between aniridia and brain anomalies with or without functional impact, such as
neurodevelopment delay or auditory dysfunction.
In the majority of cases, aniridia is a panophthalmopathy
that is characterized by the absence or hypoplasia of the iris
and is associated with other ocular anomalies, such as cataract,
foveal  hypoplasia,  corneal  opacity  (pannus),  coloboma,
anterior chamber angle (with secondary glaucoma), or optic
nerve malformations, mainly hypoplasia (OMIM 106210).
Mostly inherited in an autosomal dominant mode, aniridia can
have variable expressivity, and about one-third of the patients
are  sporadic  cases.  Mutations  in  the  Paired  Box  gene  6
(PAX6) located on chromosome 11p13 [1] have been shown
to cause aniridia [2]. PAX6 encodes a transcription factor
essential for the development of the structures and axes of the
eye [3]. Knocking out PAX6 from the mouse genome results
in the absence of the eye, the so-called Small eye (Sey) mouse
[4,5].
Correspondence  to:  Francis  L.  Munier,  M.D.,  Jules-Gonin  Eye
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Furthermore,  PAX6  plays  a  major  role  in  brain
development [6,7] where it is expressed in the telencephalon,
the diencephalon, the caudal part of the rhombencephalon, the
myelencephalon, and the spinal cord [3,8]. The early death of
a baby with a compound heterozygous PAX6 mutation has
been reported, and the brain of this child displayed major brain
and  cytoarchitectonic  abnormalities  [9].  Brain  imaging
(magnetic resonance imaging [MRI]) performed in patients
heterozygous  for  PAX6  mutations  often  reveals  various
malformations  as  well.  Absence  of  the  brain  anterior  or
posterior  commissure,  absence  of  the  pineal  gland,  and  a
present but reduced in size corpus callosum have all been
reported  [10-14].  These  anomalies  involve  the  brain
interhemispheric  fibers  and  can  thus  affect  the  auditory
functions that depend on these fibers [10].
Genotype–phenotype  correlations  have  shown  that
mutations  causing  premature  termination  codons  are
associated with aniridia and missense mutations are related to
non-aniridia phenotypes, such as isolated foveal hypoplasia,
microphthalmia, and optic nerve defects [15].
Molecular Vision 2009; 15:2074-2083 <http://www.molvis.org/molvis/v15/a223>
Received 19 July 2009 | Accepted 12 October 2009 | Published 17 October 2009
© 2009 Molecular Vision
2074The aim of this study was to analyze three families of
Egyptian  origin,  to  describe  their  clinical  phenotype,
including brain imaging, and to report the results of their
molecular screening. We present two novel and one known
nonsense mutations associated with brain anomalies.
METHODS
This study was approved by the Ethics Committee of the
Faculty of Medicine of the University of Alexandria, Egypt,
and  was  conducted  in  accordance  to  the  tenets  of  the
Declaration  of  Helsinki.  Written  informed  consent  was
obtained from each participant or parent. Ten patients with
aniridia belonging to three families of Egyptian origin were
included in this study as well as six first-degree relatives
(Figure 1). The three families were from the Governorate of
Alexandria, in northwestern Egypt. All subjects underwent
full  ophthalmic,  general,  and  neurological  examination,
respectively,  at  the  Departments  of  Ophthalmology,
Pediatrics and Neurology of the University of Alexandria,
Egypt. Special attention was paid to assessing the presence of
associated  anomalies,  such  as  Wilms’  tumor,  urogenital
anomalies,  or  mental  retardation,  in  all  subjects.  We
performed a cerebral MRI in each index patient (Patient III-1
of Family 1, IV-3 of Family 2, and I-1 of Family 3; Table 1).
MRIs  were  reviewed  by  two  different  radiologists.  MRI
acquisition techniques included conventional T1- and T2-
weighted multisection images (5-mm slice) on a GE Signa
HDx 1.5Tesla MRI (General Electric Company, Fairfield,
CT).
Figure  1.  Pedigrees  and  mutation
sequences of the three Egyptian families
with autosomal dominant aniridia. Male
and female subjects are represented by
squares  and  circles,  respectively,  and
affected family members have darkened
symbols.
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EMolecular analyses: DNA from patients was extracted
from  peripheral  leucocytes,  as  previously  described  [16].
Direct  bidirectional  resequencing  of  all  PCR-amplified
coding exons and adjacent junctions was performed with the
ABI Dye Terminator, version 1 (Applied Biosystems, Foster
City,  CA),  in  a  final  reaction  volume  of  10  μl,  and
electrophoresed on a 3130XL ABI genetic analyzer (Applied
Biosystems).  Sequences  were  compared  to  the  reference
sequence  NM_000280.3,  using  Chromas  version  2.23
(Technelysium,  Tewantin,  Australia).  The  adenine  of  the
ATG translation start site was set to 1. Primers and annealing
temperature for PAX6 exons are listed in Table 2. In short,
amplification was performed in a thermal cycler (GeneAmp
9700; Applied Biosystems), in a total volume of 30 μl. Each
PCR contained 100 ng genomic DNA, 0.9 nl of each primer,
and  15  μl  master  mix  2×  (Qiagen,  Hombrechtikon,
Switzerland), with or without betaine. PCR reactions were
performed as follows: an initial denaturation step was carried
out for 10 min followed by 35 cycles of 1 min at 92 °C, 1 min
at the specific annealing temperature (Table 2), and 1 min at
72  °C.  A  final  extension  cycle  at  72  °C  for  10  min  was
performed. Identified mutations were evaluated in 96 ethnic-
matched  controls  by  denaturing  high-performance  liquid
chromatography  (DHPLC)  on  a  WAVE  system
(Transgenomics,  Crewe,  UK).  Buffer  A  contained  0.1  M
triethylammonium acetate (TEAA; Transgenomics). Buffer B
contained 0.1 M TEAA and 25% acetonitrile HPLC grade
(Sigma-Aldrich Co., St. Louis, MO). The flow rate was set at
1.5 ml/min, and the Buffer B gradient was increased by 5%
per min for 2 min. The optimum temperature was determined
by the Wavemaker software (Transgenomic) for each DNA
fragment, and a time shift was applied as needed (Table 2).
Initial  Buffer  B  concentrations  and  temperatures  for  each
fragment are listed in Table 2.
RESULTS
Clinical  findings:  Patients  clinical  features  and  mutations
description are detailed in Table 1. All ten affected patients
from the three families had bilateral aniridia, with almost
complete absence of iris tissue at its base, and bilateral foveal
hypoplasia. Pendular nystagmus consecutive to early severely
reduced visual acuity was observed in all affected subjects,
except patient III-6 of Family 2 (Figure 1) who presented a
left exotropia. Corneal vascularization of different degrees
was  observed  in  the  three  families  (Figure  2).  Lens
abnormalities and glaucoma were present in Families 1 and 2
only. In Family 1, the two affected subjects with glaucoma
had  controlled  pressure  after  bilateral  trabeculectomy,
whereas  patient  III-6  of  Family  2  had  uncontrolled  high
pressure.  Systemic  and  neurological  examinations  were
normal in all ten affected subjects. In particular, no kidney or
urogenital  anomalies  on  ultrasonography,  no  mental
retardation, no cerebellar abnormal signs, and no olfactory or
hearing difficulties were observed or reported.
Cerebral MRI of Patients III-1 of Family 1 showed a
severe hypoplasia of the anterior commissure of the brain and
an absent pineal gland; the posterior commissure of the brain
was normal (Figure 3A). In Patient IV-3 of Family 2, a total
absence of both the pineal gland and the posterior commissure
of the brain was observed, but the anterior commissure was
normal  (Figure  3C).  Patient  I-1  of  Family  3  harbored  an
almost complete agenesis of the corpus callosum with a small
amount of remnant tissue localized at the virtual connection
between the genu and the body of the corpus callosum (Figure
4A).  In  the  same  patient,  Probst  bundles  were  identified
(Figure 4C). Concomitant ectasia of the ventricles and atrium,
hypoplasia of the optic chiasm (Figure 4C), and total absence
of the pineal gland were observed as well (Figure 4C). Both
anterior and posterior commissures of the brain were normal.
Molecular  findings:  In  Family  1,  a  c.170-174delTGGGC
mutation was identified in exon 7, generating a frameshift and
an early termination 17 codons downstream (p.L57fs17). The
mutation was present at the heterozygous state in the four
affected members of Family 1 and absent in the two unaffected
subjects (Figure 1). Family 2 also exhibited an unreported
deletion. The deletion of c.475delC in exon 8 generates a
frameshift and a new stop codon 47 amino acids downstream
(p.R159fs47). This mutation was present in the three affected
subjects and absent in the two unaffected individuals (Figure
1). The two mutations were not detected in 96 ethnically
matched healthy individuals and have not been previously
reported according to the Human PAX6 Mutation Database
[17].  In  Family  3,  the  previously  described  c.718C>T
(p.R240X)  nonsense  mutation  in  exon  9  [2,18,19]  was
detected in the two affected members and not in the unaffected
mother (Figure 1).
DISCUSSION
We report three PAX6 mutations segregating in three families
with aniridia originating from the northwestern part of Egypt.
Two of the three mutations are novel frameshifting deletions,
and one is a previously described nonsense mutation. To our
knowledge, this is the first report of aniridia mutations from
this part of the world. It is interesting to note that the pathology
of the PAX6-related genome is far from being fully determined
when one considers that only one of the identified mutants
was already known. From a clinical point of view, the ten
patients of this series harbored common but extensive features
of ocular-isolated aniridia associated with the wide spectrum
of already described MRI brain malformations. These include
absence of the pineal gland and hypogenesis of the corpus
callosum and of the anterior or posterior commissure. The
interpretation of the observed MRI malformations is limited
by  the  lack  of  a  full  assessment  of  the  neurological
development;  refined  examinations,  such  as
electroencephalogram, neurocognitive tests, or sleep study,
were not available. Nevertheless, the patients did not harbor
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2078Figure 2. Slit-lamp photographs. A: Right eye of patient II-7 from Family 1. Note the significant, heavy, corneal vascularization sparing the
nasal area. The iris base is very thin, almost invisible, a typical feature of aniridia. The patient was aphakic since cataract surgery performed
in childhood. Best-corrected visual acuity was 0.1. B: Right eye patient III-4 from Family 1 showing heavy corneal vascularization (pannus)
and superior dislocation of the lens. Almost no iris residual tissue is visible, as typically seen in aniridia. Note as well the small anterior polar
cataract and the associated faint peripheral cortical opacities. C and D: Right and left eye of patient IV-3 from Family 2. Note the bilateral
posterior polar cataract shaped like the petals of a flower and the superior lens dislocation. E and F: Fundus photographs. Right and left eye
of patient IV-1 from Family 2. Foveal hypoplasia is observed with macular pigment epithelium alterations.
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2079major  neurodevelopmental  delay  that  could  be  detected
clinically by a senior geneticist and pediatrician.
In a large genotype–phenotype correlation of the PAX6
Mutation  Database,  Tzoulaki  et  al.  [15]  established  that
mutations introducing a premature termination codon (PTC)
were predominantly associated with aniridia, whereas non-
aniridia  phenotypes,  such  as  isolated  foveal  hypoplasia,
microphthalmia, and optic nerve defects, were predominantly
caused by missense mutations. These authors showed that the
second  most  frequent  type  of  PAX6  mutations  was
frameshifting insertions or deletions and missense mutations
were the third. In the present series of patients with typical
aniridia, the three identified mutations caused a PTC, and two
of them were frameshifting deletions, thus confirming the
frequent association of PTC and of frameshifting mutations
with aniridia [15].
The  p.R240X  mutation  segregating  in  Family  3  has
previously  been  described  [2,18,19]  with  more  than  20
independent records in the PAX6 Mutation Database [17].
This  mutation  is  a  C>T  transition  that  occurs  on  a  CpG
dinucleotide, a structure known for its high mutability [20].
This CpG in exon 9, located in the homeobox coding region,
is a mutation hotspot since CpG dinucleotides of the last third
of PAX6 tend to be methylated and thus more inclined to
undergo spontaneous deamination of cytosine, resulting in
C>T transition [21]. A sense-strand deamination of CpG in a
CGA codon creates a termination codon CTA. It has been
proposed  that  nonsense-mediated  decay  (NMD),  the
mechanism responsible for the elimination of mRNAs that
contain premature termination codons before the last exon
[22],  is  highly  involved  in  aniridia  since  the  majority  of
aniridia  PAX6  mutations  introduce  premature  termination
codons  [15].  Thus,  NMD  impedes  truncated  protein
formation, and loss-of-function of one allele is responsible for
the development of aniridia through haploinsufficiency. This
mechanism may explain how different mutations and different
putative truncated proteins can induce similar phenotypes.
The Family 1 and 2 unreported mutations, p.L57fs17 and
p.R159fs47, are both likely to result in haploinsufficiency
through NMD.
Hypoplasia of the anterior commissure [10,12,14], of the
posterior  commissure  [10],  and  of  the  corpus  callosum
[10-12,14] have been reported in heterozygous carriers of
PAX6  mutations.  Absence  or  hypoplasia  of  the  anterior
commissure is present in up to one-third of PAX6 mutation
carriers [10,13]. Abnormal anterior MRI anomalies can be
associated with subtle neurological deficits, such as olfactory
difficulties  [14],  hearing  difficulties  [10],  and  deficits  in
executive and social cognition [11], or with aniridia only
[12]. We did observe anomalies of these three brain structures
in our three imaged patients (Table 1). Although no brain
anomalies can yet be directly related to any specific PAX6
mutation, we report the third observation of MRI anomalies
associated with the p.R240X mutation [10,14]. In contrast
with both Sisodiya et al. [14] and Bamiou et al. [10] who
reported  a  hypoplastic  anterior  commissure  but  a  normal
corpus callosum, we observed in Patient I-1 of Family 3 an
almost  complete  agenesis  of  the  corpus  callosum  with  a
normal  anterior  commissure  (Table  1,Figure  4C).
Interestingly,  we  observed  Probst  bundles  in  this  patient
Figure 3. Axial cerebral T2-weighted magnetic resonance images. A: Patient III-1 from Family 1. Dashed arrow: severe hypoplasia of the
anterior commissure. Arrow head: normal posterior commissure. Lower arrow: absence of the pineal gland. B: Normal magnetic resonance
imaging (MRI) images. Dashed arrow: normal anterior commissure. Arrow head: normal posterior commissure. Lower arrow: normal pineal
gland. C:  Patient IV-3 from Family 2. Dashed arrow: normal anterior commissure. Arrow head: absent posterior commissure. Lower arrow:
absent pineal gland.
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2080(Figure  4C),  which  highlights  the  severity  of  the  corpus
callosum hypogenesis in this case. Indeed, Probst bundles
represent fiber tracts that grow caudally along the medial
surface of the ipsilateral cerebral hemisphere that would have
crossed the midline in the case of normal corpus callosum
development [23]; their presence is common in patients with
corpus callosum hypogenesis and twice as frequent in patients
with corpus callosum agenesis [24].
We hypothesize that a specific mutation can cause brain
anomalies  but  that  the  brain  anomaly  can  be  expressed
differently. Being a transcription factor, PAX6 interacts with
several brain developmental genes and transcription factors,
such as the Homeobox gene expressed in ES cells, the Hesx1
gene [3], whose interaction with PAX6 could be altered by the
presence of a mutant protein causing corpus callosum and
brain  commissure  hypogenesis.  It  has  recently  been
demonstrated in mouse that the transcription factors Empty
spiracles  homeobox  2,  Emx2  and  Pax6  are  essential  for
cortical regionalization at the beginning of neuronogenesis
[25].  From  this  perspective,  one  can  hypothesize  that
abnormal interaction between mutated PAX6 protein and a
normal EMX2 protein could be responsible for the presence
of  the  interhemispheric  brain  anomalies.  Moreover,  the
possibility of digenism is not excluded with the presence of
an undetected EMX2 mutation added to the PAX6 one to result
in  corpus  callosum  and  commissure  dysgenesis.  Last,  the
existence of at least two promoters is described in the literature
to mediate Pax6 expression in different tissues [26,27]. Thus,
one  promoter  mediates  expression  in  the  brain,  and
differential PAX6  transcription  through  alternate  promoter
usage could be involved in neural development [28].
Figure 4. Coronal cerebral T2-weighted
magnetic resonance images. A: Patient
I-1 from Family 3. Dashed arrow shows
severe  hypogenesis  of  the  corpus
callosum with small amount of remnant
tissue localized at the virtual connection
between the genu and the body of the
corpus callosum; arrow head shows the
atrophic optic chiasm. B: Normal MRI
images.  Dashed  arrow  shows  normal
corpus callosum and arrow head shows
normal optic chiasm. C: Patient I-1 from
Family 3. Dashed arrow shows lateral
callosal  bundles  of  Probst,  which  are
hemispheric connection fibers that did
not cross the midline and that are seen
in  callosal  dysgenesis.  Superomedial
margins  of  the  lateral  ventricles  are
indented by the Probst bundles. Arrow
head  shows  remnants  of  the  corpus
callosum. Lower arrow shows normal
posterior commissure. D: Normal MRI
image  with  dashed  arrow  pointing
normal corpus callosum.
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2081The auditory fibers travel through the interhemispheric
pathways, and it has been demonstrated that children with
PAX6 mutations and abnormalities of the interhemispheric
pathways on MRI harbor reduced auditory capacities even in
the presence of normal audiograms [10]. We did not observe
any major clinical auditory deficits in any of the ten studied
patients,  although  the  three  patients  with  available  MRIs
showed abnormal interhemispheric pathways. However we
cannot  conclude  on  the  auditory  status  since  we  did  not
perform any specific tests, including the study of auditory-
evoked potentials.
Mitchell et al. [13] published an MRI study of 24 aniridia
patients with PAX6 mutations and found absence of the pineal
gland in 13/24 patients (54%). These authors concluded that
this observation may be common in aniridia patients. Indeed,
we have previously reported absence of the pineal gland in
aniridia patients [29] as we do in the three patients of the
present series in whom we performed MRI. As previously
mentioned, sleep study was not performed and thus we could
not  assess  the  functional  consequences  of  the  absence  of
pineal glands. Mice homozygous for mutations in the Pax6
gene  harbor  a  wide  variety  of  neurodevelopmental
abnormalities, including absence of the corpus callosum and
pineal gland [30,31].
PAX6 affects the development and function of the central
nervous system and the eye as well as the pancreas and the
hypothalamopituitary  axis  through  the  hypothalamus  [3],
which shares with the retina a common embryologic origin—
the neural plate. Unfortunately, we were not able to perform
electroretinography or endocrine testing to study the effect of
the PAX6 mutations on the retina and hypothalamopituitary
axis.
Finally,  WAGR  syndrome  (OMIM  194072),  which
includes  Wilms’  tumor,  aniridia,  genitourinary  anomalies,
and mental retardation, is caused by either microscopic or
submicroscopic  deletion  of  chromosome  11p13-p12  in  a
region containing both the Wilms tumor 1, WT1 gene and the
PAX6 genes. A contiguous syndrome, the WAGRO syndrome
(OMIM 612469), includes the features of WAGR with obesity
and is caused by a similar deletion that includes the Brain-
derived  neurotrophic  factor,  BDNF  gene  as  well.  Both
syndromes were clinically excluded by normal kidney and
urogenital ultrasonography performed on our patients.
In summary, we describe three mutations found in three
families  from  northwestern  Egypt,  adding  two  novel
mutations to the existing spectrum of PAX6 mutations. Two
of the three mutations are frameshifting small deletions and
one is a previously described nonsense mutation. While the
ten familial aniridia patients of this series harbored typical
features  of  ocular-isolated  aniridia,  we  observed  a  wide
spectrum of MRI brain malformations, including absence of
the pineal gland, hypogenesis of the corpus callosum with
Probst bundles, and hypoplasia of the anterior or posterior
commissure  in  patients  not  harboring  major  neurological
development anomalies. Correlation between phenotype and
genotype of PAX6 mutations is still in its infancy in regard to
brain  malformations.  The  wide  spectrum  of  PAX6-related
anomalies and the fact that aniridia is frequently caused by
PAX6 mutations should prompt physicians facing aniridia to
perform an examination of the central nervous system (at least
with an MRI), an ultrasonography of the kidney and of the
urinary pathways, a study of the kidney functions, and most
importantly a complete assessment of the pituitary hormones
and hypothalamic-releasing hormones.
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